TABLE 1.
References | Location | Time Period | Study, n | Positivity, n (%) | Proportion Asymptomatic, n (%) |
---|---|---|---|---|---|
Sutton et al6 | New York City | 3/22-4/18/20 | 215 | 33 (13.7) | 29 (87.9) |
Prabhu et al7 | New York City | 3/22-4/20/20 | 675 | 70 (10.4) | 55 (78.6) |
Vintzileos et al8 | New York City | 3/30-4/12/20 | 161 | 32 (19.9) | 21 (66) |
Buckley et al9 | New York City | 4/4-4/15/20 | 307 | 50 (16.3) | 50 (100) |
Blitz et al10 | New York City/Long Island | 4/2- 4/9/ 20 | 375 | 64 (17.1) | 45 (70.3) |
Campbell et al11 | Southern Connecticut | 4/2-4/29/20 | 770 | 30 (3.9) | 22 (73.3) |
Berkowitz et al12 | Ohio | 5/1-5/15/20 | 492 | 10 (2.0) | 7 (70) |
Goldfarb et al13 | Boston | 4/18- 5/5/20 | 757 | 20 (2.6) | 9 (45) |
Fassett et al14 | California | 4/6-5/11/20 | 3923 | 17 (0.4) | 17 (100) |
Yassa et al15 | Turkey | 4/27-5/27/20 | 296 | 23 (7.8) | 12 (525) |
Tanacan et al16 | Turkey | 4/15-6/5/20 | 206 | 3 (1.5) | 3 (100) |
Doria et al17 | Portugal | 3/25-4/15/20 | 103 | 12 (11.4) | 11 (91.6) |
Cardona Perez et al18 | Mexico | 4/22-5/25/20 | 240 | 70 (29.0) | 60 (86) |
The table demonstrates US and international single-center studies evaluating test results for universal SARS-CoV-2 screening for obstetric hospitalizations.
SARS-CoV-2 indicates severe acute respiratory syndrome coronavirus 2.